A detailed history of Voya Investment Management LLC transactions in Biogen Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 80,774 shares of BIIB stock, worth $12.8 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
80,774
Previous 94,494 14.52%
Holding current value
$12.8 Million
Previous $21.9 Million 28.52%
% of portfolio
0.02%
Previous 0.03%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$189.07 - $236.8 $2.59 Million - $3.25 Million
-13,720 Reduced 14.52%
80,774 $15.7 Million
Q2 2024

Aug 14, 2024

SELL
$190.52 - $236.72 $684,728 - $850,771
-3,594 Reduced 3.66%
94,494 $21.9 Million
Q1 2024

May 15, 2024

SELL
$212.02 - $267.71 $3.68 Million - $4.65 Million
-17,380 Reduced 15.05%
98,088 $21.2 Million
Q4 2023

Feb 14, 2024

BUY
$222.59 - $267.94 $471,668 - $567,764
2,119 Added 1.87%
115,468 $29.9 Million
Q3 2023

Nov 14, 2023

SELL
$253.3 - $285.89 $1 Million - $1.13 Million
-3,960 Reduced 3.38%
113,349 $29.1 Million
Q2 2023

Aug 14, 2023

SELL
$275.25 - $318.06 $856,302 - $989,484
-3,111 Reduced 2.58%
117,309 $33.4 Million
Q1 2023

May 15, 2023

BUY
$256.56 - $292.34 $456,676 - $520,365
1,780 Added 1.5%
120,420 $33.5 Million
Q4 2022

Feb 14, 2023

BUY
$252.44 - $306.72 $752,018 - $913,718
2,979 Added 2.58%
118,640 $32.9 Million
Q3 2022

Mar 03, 2023

SELL
$194.69 - $268.46 $579,981 - $799,742
-2,979 Reduced 2.51%
115,661 $30.9 Million
Q3 2022

Nov 14, 2022

BUY
$194.69 - $268.46 $11.3 Million - $15.6 Million
58,254 Added 101.48%
115,661 $30.9 Million
Q2 2022

Aug 15, 2022

SELL
$187.54 - $223.02 $1.93 Million - $2.29 Million
-10,283 Reduced 15.19%
57,407 $11.7 Million
Q1 2022

May 16, 2022

SELL
$193.77 - $244.14 $8.06 Million - $10.1 Million
-41,570 Reduced 38.05%
67,690 $14.3 Million
Q4 2021

Feb 14, 2022

BUY
$223.92 - $287.77 $6.66 Million - $8.56 Million
29,757 Added 37.43%
109,260 $26.2 Million
Q3 2021

Nov 15, 2021

SELL
$282.99 - $369.05 $3.5 Million - $4.56 Million
-12,364 Reduced 13.46%
79,503 $22.5 Million
Q2 2021

Aug 16, 2021

SELL
$259.0 - $414.71 $5.81 Million - $9.3 Million
-22,434 Reduced 19.63%
91,867 $31.8 Million
Q1 2021

May 17, 2021

SELL
$242.95 - $284.63 $1.29 Million - $1.51 Million
-5,314 Reduced 4.44%
114,301 $32 Million
Q4 2020

Feb 16, 2021

SELL
$236.26 - $355.63 $6.53 Million - $9.83 Million
-27,650 Reduced 18.78%
119,615 $29.3 Million
Q3 2020

Nov 16, 2020

SELL
$264.77 - $305.71 $2.45 Million - $2.83 Million
-9,265 Reduced 5.92%
147,265 $41.8 Million
Q2 2020

Aug 14, 2020

SELL
$258.66 - $342.55 $1.81 Million - $2.4 Million
-7,006 Reduced 4.28%
156,530 $41.9 Million
Q1 2020

May 15, 2020

BUY
$268.85 - $341.04 $6.66 Million - $8.45 Million
24,778 Added 17.86%
163,536 $51.7 Million
Q4 2019

Feb 14, 2020

SELL
$220.06 - $304.07 $485,672 - $671,082
-2,207 Reduced 1.57%
138,758 $41.2 Million
Q3 2019

Nov 14, 2019

SELL
$217.44 - $243.88 $784,740 - $880,162
-3,609 Reduced 2.5%
140,965 $32.8 Million
Q2 2019

Aug 14, 2019

SELL
$219.29 - $241.72 $152,625 - $168,237
-696 Reduced 0.48%
144,574 $33.8 Million
Q1 2019

May 15, 2019

SELL
$216.71 - $338.96 $176 Million - $276 Million
-813,189 Reduced 84.84%
145,270 $34.3 Million
Q4 2018

Feb 14, 2019

BUY
$278.5 - $352.75 $5.37 Million - $6.8 Million
19,291 Added 2.05%
958,459 $288 Million
Q3 2018

Nov 14, 2018

BUY
$293.51 - $383.83 $243 Million - $317 Million
826,232 Added 731.59%
939,168 $332 Million
Q2 2018

Aug 14, 2018

SELL
$257.52 - $306.91 $2.93 Million - $3.5 Million
-11,393 Reduced 9.16%
112,936 $32.8 Million
Q1 2018

May 15, 2018

SELL
$260.13 - $367.91 $98.3 Million - $139 Million
-377,897 Reduced 75.24%
124,329 $34 Million
Q4 2017

Feb 14, 2018

BUY
$307.64 - $344.58 $8.41 Million - $9.42 Million
27,339 Added 5.76%
502,226 $160 Million
Q3 2017

Nov 14, 2017

BUY
$281.15 - $329.69 $134 Million - $157 Million
474,887
474,887 $149 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $22.7B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.